Grand Gallery Inc. COSG
0.06 USD 0.00 (+0.00%)
At closeNov 2, 2026, 4:00 PM EST
0.028 Day range 0.028
0.0001 52-week range 0.3639
- YTD
- +525.00%
- 1 year
- +212.50%
- Market cap
- 1.91M
- EPS (ttm)
- 20.07
- P/E ratio
- 0.00
- YTD return
- +525.00%
- 1-year return
- +212.50%
- Volume
- 100
- Avg volume
- 217
- Open
- 0.028
- Previous close
- 0.0625
- Day's range
- 0.028 – 0.028
- 52-week range
- 0.0001 – 0.3639
2Y -1.9375 (-96.88%)
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2024 | Sep 1, 2024 | 0.00 | 0.00 | — | — |
| Aug 14, 2024 | Jun 1, 2024 | 0.00 | 0.00 | — | — |
| May 20, 2024 | Mar 1, 2024 | 0.00 | 0.00 | — | — |
| Nov 22, 2023 | Sep 1, 2023 | 0.00 | 0.00 | — | — |
| Aug 21, 2023 | Jun 1, 2023 | 0.00 | -0.01 | — | — |
| May 22, 2023 | Mar 1, 2023 | 0.00 | -0.01 | — | — |
News
Cosmos Group (OTCMKTS:COSG) Share Price Crosses Above 200 Day Moving Average – Should You Sell? 
Cosmos Health Expands E-Commerce and Subscription Business to Australia, New Zealand and the Broader Oceania Region, With Sales Already Underway 
Cosmos Health CEO Greg Siokas Issues Letter to Shareholders Highlighting Record 2026 Revenue, U.S. Subscription Growth and Global Expansion 
Cosmos Health Provides Update on United States Business; Q4 2026 U.S. Revenue Expected to Reach $15 Million, with Gross Profit of $10.5 Million; Active U.S. Subscriptions Up 42% from 6,287 to 8,940 in Just Five Days 
Cosmos Health Reaches 6,287 Active U.S. Subscriptions, Substantially All Added Since Mid-September, with 60.5% of Online Checkout Orders Including a Subscription 
Cosmos Health Reports Record Single-Day Direct-to-Consumer Sales in the United States Above $92,000, with $902,000 in Sales Over the Past 30 Days 
Cosmos Health Reports Record Preliminary Nine-Month Revenue of $54.3 Million, Up 19% Year Over Year; Delivers Record Q3 Revenue of $17.4 Million and Reaffirms 2026 Revenue Outlook of Over $90 Million 
Cosmos Health's Brands Reach More Than 40 Countries Across Europe, the Middle East, North America and Asia, Addressing Global Markets Estimated at Approximately $946 Billion 
Cosmos Health's CosmoFarm Reaches Record Annualized Revenue Above $60 Million, Up 4.3x Under Cosmos Health Ownership, as Robotics and AI Build Capacity to Support Over $100 Million in Annualized Revenue 
Cosmos Health's Contract Manufacturing Division Surpasses $20 Million in Implied Revenue and $18 Million in Implied Gross Profit Across Its Record 32.7 Million-Unit Production Pipeline
Your note
Sign in to keep a note on COSG — it syncs with the Stock Master app.